Several executive orders recently signed by US President Donald Trump may have significant implications for the US Food and Drug Administration ...
What will the industry face or achieve in 2025? These trends will be critical in medical device cybersecurity.
The FDA is urging Congress to implement mandatory medical device shortage reporting to address growing vulnerabilities in the ...
we will actively support the rapid market entry of innovative medical devices utilizing advanced technologies, including applying priority reviews under GMP (Good Manufacturing Practice ...
The designation also lines them up for priority FDA review. In 2023, more than 30 medical devices were given this same breakthrough designation, and almost 1,000 have been authorized total.
“Sunvozertinib’s priority review designation marks an important regulatory milestone in Dizal’s efforts to address unmet medical needs worldwide.” According to the release, sunvozertinib ...
Neurotech Pharmaceuticals’ eye cell therapy implant has faced a setback as the US Food and Drug Administration (FDA) has ...